{"id":60853,"date":"2024-02-28T07:11:54","date_gmt":"2024-02-28T07:11:54","guid":{"rendered":"https:\/\/medsname.com\/iotim-eye-drops\/"},"modified":"2026-04-30T10:23:41","modified_gmt":"2026-04-30T10:23:41","slug":"iotim-eye-drops","status":"publish","type":"product","link":"https:\/\/medsbase.com\/da\/iotim-eye-drops\/","title":{"rendered":"Iotim \u00f8jendr\u00e5ber"},"content":{"rendered":"

<\/p>\n

\n

\u26a1 Quick Answer \u2014 What is Iotim Eye Drops?<\/h3>\n

Iotim Eye Drops is Timolol maleate 0.5%, a topical beta-blocker eye drop that lowers eye pressure 20\u201325% in glaucoma by reducing aqueous humour production. Non-selective \u2014 contraindicated in asthma, severe COPD, sinus bradycardia, and AV block. Used 1\u20132 times daily.<\/p>\n<\/div>\n

Hvorfor bestille fra MedsBase?<\/strong> Produceret af en WHO-GMP-certificeret fabrikant \u00b7 Diskret emballage \u00b7 Verdensomsp\u00e6ndende forsendelse \u00b7 1.400+ verificerede kundeanmeldelser<\/a><\/div>\n

\ud83d\udce6 Hver ordre er d\u00e6kket af vores Reshipment Assurance Policy<\/strong><\/a> \u2014 hvis din pakke ikke ankommer inden for 20 hverdage, sender vi en erstatning.<\/p>\n

Hvorfor bestille fra MedsBase<\/h3>\n

Iotim Eye Drops is sourced from a WHO-GMP certified manufacturer and shipped worldwide in plain, discreet packaging. Every order is covered by our Reshipment Assurance Policy<\/a> \u2014 hvis den ikke er ankommet inden for 20 hverdage, sender vi en ny uden ekstra omkostninger. Underst\u00f8ttet af 1.400+ verificerede kundeanmeldelser.<\/p>\n

What is Iotim Eye Drops?<\/h2>\n

Iotim Eye Drops is manufactured by FDC and contains Timolol maleate 0.5% as a sterile ophthalmic solution. Timolol is a non-selective beta-blocker that blocks both beta-1 (cardiac) and beta-2 (bronchial) adrenergic receptors. It is one of the oldest and most studied IOP-lowering drugs.<\/p>\n

S\u00e5dan virker det<\/h2>\n

Timolol maleate blocks beta-adrenergic receptors on the ciliary epithelium, reducing the rate of aqueous humour secretion. This decreases the volume of fluid in the anterior chamber and lowers IOP by approximately 20\u201325%. Unlike prostaglandin analogs (which work on outflow), beta-blockers work on the production side of the equation \u2014 making them additive with prostaglandins and CAIs.<\/p>\n

Indikationer & Dosering<\/h2>\n\n\n\n\n\n\n\n
Indikation<\/th>\nDosis<\/th>\n<\/tr>\n<\/thead>\n
\u00c5benvinklet glaukom<\/td>\n1 dr\u00e5be i det\/de ber\u00f8rte \u00f8je(r) to gange dagligt (morgen og aften)<\/td>\n<\/tr>\n
Okt\u00e6r hypertension<\/td>\n1 dr\u00e5be to gange dagligt \u2014 samme som POAG<\/td>\n<\/tr>\n
Engangsdaglige formuleringer (timolol XE \/ gel-dannende)<\/td>\nForskellige flasker \u2014 f\u00f8lg etiketten<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n
Kardiale og respiratoriske advarselstegn.<\/strong> Non-selective timolol is kontraindikeret<\/strong> in asthma, severe COPD, sinus bradycardia, second\/third-degree AV block, decompensated heart failure, and cardiogenic shock. Significant systemic absorption occurs through the nasolacrimal duct \u2014 bronchospasm and bradycardia have been reported in glaucoma patients.<\/div>\n

Bivirkninger<\/h2>\n

Lokale (\u00f8je):<\/strong> stikkende fornemmelse ved inddrypning, t\u00f8rre \u00f8jne, sl\u00f8ret syn, conjunctival hyper\u00e6mi, corneal an\u00e6stesi (sj\u00e6ldent).<\/p>\n

Systemisk (fra absorption):<\/strong> bradycardia, hypotension, fatigue, depression, decreased exercise tolerance, decreased libido, bronchospasm in reactive-airway patients, masking of hypoglycaemia signs in diabetics.<\/p>\n

Punktumokklusionsteknik.<\/strong> Efter inddrypning af dr\u00e5ben skal du forsigtigt trykke p\u00e5 det indre \u00f8jenkrog (n\u00e6r n\u00e6sen) i 1\u20132 minutter med lukkede \u00f8jne. Dette komprimerer de nasolakrimale kanalikler og reducerer systemisk absorption med ~70%, hvilket mindsker risikoen for bradykardi, tr\u00e6thed og bronkospasmer.<\/div>\n

Advarsler & Kontraindikationer<\/h2>\n